Summary

Eligibility
for people ages 18-80 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCSD
Dates
study started
completion around
Principal Investigator
by Jejo Koola, MD (ucsd)
Headshot of Jejo Koola
Jejo Koola

Description

Summary

The investigators will establish how well a novel, quick, and painless way of measuring muscle activity from the mouth and throat works for detecting sleep apnea. This technology is called transmembraneous electromyography (tmEMG). Leveraging two technologies, a new probe capable of recording muscle activity by lightly touching the muscle, as well as a machine learning model for signal interpretation, the investigators will conduct an initial observational feasibility study in phase 1, followed by a larger observational cohort study in phase 2 to assess the performance of deep learning enhanced tmEMG. The study will address a critical unmet need in sleep apnea diagnostics: the availability of an inexpensive, accurate diagnostic test for screening at point of care.

Official Title

BREATH: Breakthrough Research in Electromyography for the Assessment of Sleep-disordered BreaTHing

Details

Given night-to-night variability and/or changes in OSA severity over time, study participants will undergo a 2-night home sleep test to verify the results of a prior sleep test as part of our screening activities. After verifying that the results of the home sleep test are concordant with the participant's previously administered clinical sleep study, they will be brought to the study clinic. Participants from both arms will undergo testing of four oropharyngeal muscles: left and right palatoglossus, left and right genioglossus. Using the transmembranous electromyography (tmEMG) probe, recordings will be obtained from each muscle using various provocative maneuvers. For the palatoglossus, recordings will be obtained during normal shallow inspiration as well as deep forceful inspiration. For the genioglossus, recordings will be obtained during maximal voluntary contraction as well sub-maximal voluntary contraction of the tongue against resistance (either the buccal mucosa or the front incisors).

Keywords

Obstructive Sleep Apnea (OSA), OSA, Healthy Volunteers, Electromyography, sleep study, polysomnography, Sleep Apnea Syndromes, Obstructive Sleep Apnea, Electromyography (EMG) of the Oropharynx

Eligibility

You can join if…

Open to people ages 18-80

  1. Age 18 years or older
  2. Subject must have completed a prior sleep test.
    1. Subjects may be recruited if the last prior sleep test either determined that they do not have sleep apnea OR they have moderate to severe sleep apnea. No sleep apnea is defined by AHI < 5; moderate to severe sleep apnea is defined by AHI >= 15.
    2. To be fully eligible, the prior test result needs to be verified via 2-night home sleep test (using the average AHI from the 2 nights). If OSA status (i.e., AHI<5/h or >=15/h) from the 2-night HST vs last prior sleep test is discordant, then participants will be excluded as screen failures.

You CAN'T join if...

  1. Current use of OSA therapy, including PAP (positive airway pressure) or non-invasive ventilation on a daily basis
  2. Prior uvulopalatopharyngoplasty surgery for sleep apnea.
  3. Inability to install WatchPAT ONE application on smartphone or tablet or unwillingness/inability to use the WatchPAT ONE home sleep study device
  4. Prisoners are excluded due to ethical, legal, and practical concerns
  5. Individuals who are pregnant are excluded due to temporary changes in habitus, fluid shifts, and potential changes to oropharyngeal musculature may impact tmEMG assessment. This important subpopulation will be investigated in a later phase study.
  6. Inability to stop tobacco, marijuana, or vaping on the day of testing.
  7. Binge alcohol use behaviors (4+ drinks on the same occasion on 5+ days in the past month).
  8. Medication use that may cause central apnea that in the judgment of the investigators could impact the safety or results of the study
  9. Allergy to benzocaine topical anesthetic or other ester class local anesthetics (lidocaine, etc.)
  10. Current psychiatric illness other than treated mood disorders
  11. Unable or unwilling to provide informed consent or comply with research procedures
  12. Active Cancer due to potential interference with study results
  13. Major comorbidities which in the judgment of the investigators could impact the safety or results of the study
  14. Inability to sign consent and participate in the study in English. This study involves use of an investigational device; the technical nature of the study and the consenting process and consent form make it impractical to include subjects who cannot participate in English.

Location

  • University of California San Diego accepting new patients
    San Diego California 92037 United States

Lead Scientist at University of California Health

  • Jejo Koola, MD (ucsd)
    Dr. Jejo Koola joined UCSD faculty in 2016. He received his MD degree from the Medical University of South Carolina and subsequently completed his residency in Internal Medicine at the Medical College of Virginia in Richmond, Virginia in 2011.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Diego
ID
NCT06944782
Study Type
Observational
Participants
Expecting 60 study participants
Last Updated